ImmunoCellular Therapeutics, Ltd. | 2013 | FY | 3


The below table summarizes the warrant liability activity for the years ended December 31, 2013, 2011 and 2010. The loss included in earnings is reflective of several factors including the increase in the Company’s stock during the years ended December 31, 2013, 2011 and 2010.

 

 

  

2013

 

 

2012

 

 

2011

 

Beginning Balance, January 1

 

$

2,852,880

 

 

$

2,157,408

 

 

$

2,581,871

 

Issuance of warrants and effect of repricing

 

 

 

 

 

397,294

 

 

 

 

Exercise of warrants

 

 

(1,145,659

)

 

 

(1,981,745

)

 

 

2,476,790

 

(Gain) or loss included in earnings

 

 

(642,411

)

 

 

2,279,923

 

 

 

(2,901,253

)

Transfers in and/or out of Level 3

 

 

 

 

 

 

 

 

 

Ending Balance, December 31

 

$

1,064,810

 

 

$

2,852,880

 

 

$

2,157,408

 

 


us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock